although usual daily administration of sm-108 exhibited poor efficacy , the intermittent multiple administration of sm-108 exhibited potent antitumor activity against a wide variety of tumors , such as ehrlich carcinoma , p388 , 6-mercaptopurine-sensitive and -resistant l1210 , lewis lung carcinoma , colon 26 adenocarcinoma , and sarcoma 180 .
C0007097
carcinoma
C0243038
lewis lung carcinoma